SONG PAUL Y. (Chief Executive Officer) purchased 0.1% of their position (151.36 shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $500.23 — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/7/2023ACC: 0001209191-23-057748
DirectorOfficer· Chief Executive Officer
Since Sep 2023
+151.36
Net shares
Net buyer
$500.23
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
151.36 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+75.30
Price / share
$3.32
Trade value
$250.00
% of position
0.0%
12/6/2023
170.97K→171.04K
Common Stock
Direct
Shares
+76.06
Price / share
$3.29
Trade value
$250.24
% of position
0.0%
12/7/2023
171.04K→171.12K
Total
Net shares
+151.36
Net value
$500.23
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/6/2023 | P · Purchase | +75.30 | $3.32 | $250.00 | 0.0% | 170.97K | 171.04K |
| Common Stock Direct | 12/7/2023 | P · Purchase | +76.06 | $3.29 | $250.24 | 0.0% | 171.04K | 171.12K |
| Total | +151.36 | $500.23 | ||||||
Derivative Transactions0
No derivative transactions reported